cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.16625191
title: Additional file 1 of Contrasting effects of the alkaloid ricinine on the capacity of Anopheles gambiae and Anopheles coluzzii to transmit Plasmodium falciparum

description: Additional file 1. Data for experiment 1 used for Fig.1 and statistical analyses.
DOI: 10.6084/m9.figshare.16625191.v1
title: Additional file 1 of Contrasting effects of the alkaloid ricinine on the capacity of Anopheles gambiae and Anopheles coluzzii to transmit Plasmodium falciparum

description: Additional file 1. Data for experiment 1 used for Fig.1 and statistical analyses.
DOI: 10.6084/m9.figshare.16625194
title: Additional file 2 of Contrasting effects of the alkaloid ricinine on the capacity of Anopheles gambiae and Anopheles coluzzii to transmit Plasmodium falciparum

description: Additional file 2. Data for experiment 2 used for Fig.2 and statistical analyses.
DOI: 10.6084/m9.figshare.16625194.v1
title: Additional file 2 of Contrasting effects of the alkaloid ricinine on the capacity of Anopheles gambiae and Anopheles coluzzii to transmit Plasmodium falciparum

description: Additional file 2. Data for experiment 2 used for Fig.2 and statistical analyses.
DOI: 10.6084/m9.figshare.16625197
title: Additional file 3 of Contrasting effects of the alkaloid ricinine on the capacity of Anopheles gambiae and Anopheles coluzzii to transmit Plasmodium falciparum

description: Additional file 3. Data for experiment 3 used for Fig.3 and statistical analyses.
DOI: 10.6084/m9.figshare.16625200
title: Additional file 4 of Contrasting effects of the alkaloid ricinine on the capacity of Anopheles gambiae and Anopheles coluzzii to transmit Plasmodium falciparum

description: Additional file 4. Rscript used for all Figures and statistical analyses.
DOI: 10.6084/m9.figshare.16625197.v1
title: Additional file 3 of Contrasting effects of the alkaloid ricinine on the capacity of Anopheles gambiae and Anopheles coluzzii to transmit Plasmodium falciparum

description: Additional file 3. Data for experiment 3 used for Fig.3 and statistical analyses.
DOI: 10.6084/m9.figshare.16625200.v1
title: Additional file 4 of Contrasting effects of the alkaloid ricinine on the capacity of Anopheles gambiae and Anopheles coluzzii to transmit Plasmodium falciparum

description: Additional file 4. Rscript used for all Figures and statistical analyses.
DOI: 10.6084/m9.figshare.16625392.v1
title: Additional file 1 of A higher bacterial inward BCAA transport driven by Faecalibacterium prausnitzii is associated with lower serum levels of BCAA in early adolescents

description: Additional file 1: Table S1. Identified KEGG Orthologs involved in bacterial BCAA biosynthesis. Table S2. Identified KEGG Orthologs involved in bacterial BCAA transport. Table S3. Partial Spearman Correlations between inward transport gene abundance and HOMA-IR levels. Table S4. Concentration of fecal short-chain fatty acids. Table S5. Characteristics of the Mexican early adolescents included in the extended dataset.
DOI: 10.6084/m9.figshare.16625392
title: Additional file 1 of A higher bacterial inward BCAA transport driven by Faecalibacterium prausnitzii is associated with lower serum levels of BCAA in early adolescents

description: Additional file 1: Table S1. Identified KEGG Orthologs involved in bacterial BCAA biosynthesis. Table S2. Identified KEGG Orthologs involved in bacterial BCAA transport. Table S3. Partial Spearman Correlations between inward transport gene abundance and HOMA-IR levels. Table S4. Concentration of fecal short-chain fatty acids. Table S5. Characteristics of the Mexican early adolescents included in the extended dataset.
DOI: 10.6084/m9.figshare.16625416
title: Additional file 2 of Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome

description: Additional file 2. Supplementary file of statistics.
DOI: 10.6084/m9.figshare.16625416.v1
title: Additional file 2 of Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome

description: Additional file 2. Supplementary file of statistics.
DOI: 10.6084/m9.figshare.16625489
title: Additional file 1 of A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer

description: Additional file 1: Supplementary Material S1. Supplementary Fig. S1. Overall survival rates in the study cohort, Supplementary Fig. S2. Calibration plot for the prognostic model, Supplementary Table S1. Demographic and clinic-pathological characteristics of study population (N = 93), Supplementary Table S2. Platinum plus fluoropyrimidine-based chemotherapy combined treatments used in gastric cancer patients (N = 93), Supplementary Table S3. Grades of toxicity in gastric cancer patients by the Common Toxicity Criteria for Adverse Events (CTCAE) 4.0, Supplementary Table S4. Sex subgroup association analysis of the SNPs DPYD (rs1801265). Supplementary Table S5. Models for hematological grade ≥ 3 toxicity in gastric cancer patients treated with platinum/fluoropyridines -based chemotherapy using multivariate analysis. Supplementary Table S6. Models for gastrointestinal grade ≥ 3 toxicity in gastric cancer patients treated with platinum/fluoropyridines -based chemotherapy using multivariate analysis. Supplementary Table S7. Models for neurological grade ≥ 3 toxicity in gastric cancer patients treated with platinum/fluoropyridines -based chemotherapy using multivariate analysis. Supplementary Table S8. Genotypic and allelic frequencies for the analyzed polymorphisms, Supplementary Table S9. ID assay for each of the analyzed polymorphisms. Supplementary Table S10. SNPs selection based in score for fluoropyrimidines. Supplementary Table S11. Final score for fluoropyrimidines. Supplementary Table S12. SNPs selection based in score for platinums. Supplementary Table S13. Final score for platinums. Supplementary Table S14. Sensitivity, specificity and accuracy calculations from a 2 × 2 confusion matrix. Supplementary Methods: Details of chemotherapy schemes, SNPs selection and classifications algorithm used. Supplementary Data File 1. All raw data used in this study.
DOI: 10.6084/m9.figshare.16625489.v1
title: Additional file 1 of A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer

description: Additional file 1: Supplementary Material S1. Supplementary Fig. S1. Overall survival rates in the study cohort, Supplementary Fig. S2. Calibration plot for the prognostic model, Supplementary Table S1. Demographic and clinic-pathological characteristics of study population (N = 93), Supplementary Table S2. Platinum plus fluoropyrimidine-based chemotherapy combined treatments used in gastric cancer patients (N = 93), Supplementary Table S3. Grades of toxicity in gastric cancer patients by the Common Toxicity Criteria for Adverse Events (CTCAE) 4.0, Supplementary Table S4. Sex subgroup association analysis of the SNPs DPYD (rs1801265). Supplementary Table S5. Models for hematological grade ≥ 3 toxicity in gastric cancer patients treated with platinum/fluoropyridines -based chemotherapy using multivariate analysis. Supplementary Table S6. Models for gastrointestinal grade ≥ 3 toxicity in gastric cancer patients treated with platinum/fluoropyridines -based chemotherapy using multivariate analysis. Supplementary Table S7. Models for neurological grade ≥ 3 toxicity in gastric cancer patients treated with platinum/fluoropyridines -based chemotherapy using multivariate analysis. Supplementary Table S8. Genotypic and allelic frequencies for the analyzed polymorphisms, Supplementary Table S9. ID assay for each of the analyzed polymorphisms. Supplementary Table S10. SNPs selection based in score for fluoropyrimidines. Supplementary Table S11. Final score for fluoropyrimidines. Supplementary Table S12. SNPs selection based in score for platinums. Supplementary Table S13. Final score for platinums. Supplementary Table S14. Sensitivity, specificity and accuracy calculations from a 2 × 2 confusion matrix. Supplementary Methods: Details of chemotherapy schemes, SNPs selection and classifications algorithm used. Supplementary Data File 1. All raw data used in this study.
DOI: 10.6084/m9.figshare.16625512
title: Additional file 3 of Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences

description: Additional file 3: Supplementary Table 1. Differentially abundant modules and pathways between CF and control infants. Supplementary Table 2. Differentially abundant modules and pathways between exclusively breast fed and exclusively formula fed CF infants. Supplementary Table 3. Differentially abundant modules and pathways between exclusively breast fed and exclusively formula fed healthy infants. Supplementary Table 4. Differentially abundant modules and pathways between CF infants on antibiotics and off antibiotics. Supplementary Table 5. FishTaco-estimated contributions of taxonomic drivers to functional shifts for within-CF dietary and antibiotics usage comparisons. Supplementary Table 6. Differentially abundant modules and pathways between control infants various dietary and antibiotics usage cohorts of CF infants. Supplementary Table 7. MIMOSA-estimated contributions of taxa to variation in CF infant fecal metabolites at month 12. Supplementary Table 8. Summary of infant diet and antibiotic statistics by age.
DOI: 10.6084/m9.figshare.16625512.v1
title: Additional file 3 of Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences

description: Additional file 3: Supplementary Table 1. Differentially abundant modules and pathways between CF and control infants. Supplementary Table 2. Differentially abundant modules and pathways between exclusively breast fed and exclusively formula fed CF infants. Supplementary Table 3. Differentially abundant modules and pathways between exclusively breast fed and exclusively formula fed healthy infants. Supplementary Table 4. Differentially abundant modules and pathways between CF infants on antibiotics and off antibiotics. Supplementary Table 5. FishTaco-estimated contributions of taxonomic drivers to functional shifts for within-CF dietary and antibiotics usage comparisons. Supplementary Table 6. Differentially abundant modules and pathways between control infants various dietary and antibiotics usage cohorts of CF infants. Supplementary Table 7. MIMOSA-estimated contributions of taxa to variation in CF infant fecal metabolites at month 12. Supplementary Table 8. Summary of infant diet and antibiotic statistics by age.
DOI: 10.6084/m9.figshare.16625588
title: Additional file 1 of Finding functional associations between prokaryotic virus orthologous groups: a proof of concept

description: Additional file 1. Mapping of interacting RefSeq protein pairs to their best matching pVOGs with the reported E-value and bit score
DOI: 10.6084/m9.figshare.16625588.v1
title: Additional file 1 of Finding functional associations between prokaryotic virus orthologous groups: a proof of concept

description: Additional file 1. Mapping of interacting RefSeq protein pairs to their best matching pVOGs with the reported E-value and bit score
DOI: 10.6084/m9.figshare.16625603
title: Additional file 6 of Finding functional associations between prokaryotic virus orthologous groups: a proof of concept

description: Additional file 6. Main table containing all processed pVOG pairs, their predicted label (0 for negative, 1 for positive), prediction probability, available annotations (raw and processed) and features values. Accessible via https://zenodo.org/record/4576466
DOI: 10.6084/m9.figshare.16625137
title: Biochar reduces GHGs from paddy fields

description: We used melaleuca and rice husk biochar amending to the topsoil layer in the rice paddy field. This approach significantly reduced CH4 and N2O emissions and improved soil mineralization and physiochemical properties.
DOI: 10.6084/m9.figshare.16625137.v1
title: Biochar reduces GHGs from paddy fields

description: We used melaleuca and rice husk biochar amending to the topsoil layer in the rice paddy field. This approach significantly reduced CH4 and N2O emissions and improved soil mineralization and physiochemical properties.
DOI: 10.6084/m9.figshare.16574234
title: counts_anno.xlsx

description: RNASeq of AMC-HN-8 cell after DIAPH1 knockdown
DOI: 10.6084/m9.figshare.16625641
title: Simulation_data

description: This is the simulation data for my manuscript "A Simple Condensation Model for the H2SO4-H2O Gas-cloud System on Venus".
DOI: 10.6084/m9.figshare.16625641.v1
title: Simulation_data

description: This is the simulation data for my manuscript "A Simple Condensation Model for the H2SO4-H2O Gas-cloud System on Venus".
DOI: 10.6085/aa/pohx00_xxxitv2xlsr01_20190319.50.1
title: PISCO: Intertidal: site temperature data: Port Orford Head, Oregon, USA (POHX00)

description: This metadata record describes a mix of intertidal seawater and air temperature data collected at Port Orford Head, Oregon, USA by PISCO. Measurements were collected using Onset Tidbit V2 Temp Data Logger (Onset Computer Corp. UTBI-001) beginning 2019-03-19. Site temperature loggers are bolted down in a wire cage at various locations within each site. Mussel growth temperature loggers are bolted down in a wire cage at high, mid, or low positions within a mussel bed. Temperature is recorded at 10.0 minute intervals.
DOI: 10.6084/m9.figshare.16625917
title: Simulated data of Dai et al. 2021

description: This is the data for our simulation
DOI: 10.6084/m9.figshare.16625917.v1
title: Simulated data of Dai et al. 2021

description: This is the data for our simulation
DOI: 10.14278/rodare.1185
title: Advancement of Mineral Processing Simulation Platforms for the Integration of Water Quality – Process Performance Interactions in Water Management Systems (Raw Data)

description: Files are containing the raw data of the dissertation: Title: <strong>Advancement of Mineral Processing Simulation Platforms for the Integration of Water Quality – Process Performance Interactions in Water Management Systems</strong> Author: <strong>M.Sc. Bruno Benjamin Xavier Michaux</strong> Faculty: <strong>Faculty of Mechanical, Process and Energy Engineering of the Technische Universität Bergakademie Freiberg</strong> Year: <strong>2021</strong> It contains 3 Excel sheets: One for the flotation kinetics data One for the water composition data in flotation One for the water composition data in the mill. Furthermore it contains a student report from 2017 which is describing the preparation of the synthetic water by Miaad Farhan Fadami<br> Research Intern<br> miaad.farhanfadami@mail.mcgill.ca
DOI: 10.14278/rodare.1184
title: Advancement of Mineral Processing Simulation Platforms for the Integration of Water Quality – Process Performance Interactions in Water Management Systems (Raw Data)

description: Files are containing the raw data of the dissertation: Title: <strong>Advancement of Mineral Processing Simulation Platforms for the Integration of Water Quality – Process Performance Interactions in Water Management Systems</strong> Author: <strong>M.Sc. Bruno Benjamin Xavier Michaux</strong> Faculty: <strong>Faculty of Mechanical, Process and Energy Engineering of the Technische Universität Bergakademie Freiberg</strong> Year: <strong>2021</strong> It contains 3 Excel sheets: One for the flotation kinetics data One for the water composition data in flotation One for the water composition data in the mill. Furthermore it contains a student report from 2017 which is describing the preparation of the synthetic water by Miaad Farhan Fadami<br> Research Intern<br> miaad.farhanfadami@mail.mcgill.ca
DOI: 10.5281/zenodo.5507589
title: goosynthpart6

description: goosynthpart6
DOI: 10.5281/zenodo.5507588
title: goosynthpart6

description: goosynthpart6
DOI: 10.6084/m9.figshare.14602677.v2
title: Historical Migration Data Source

description: The data includes original child ladder migration data, intermediate, and output files to help produce flow map time series.
DOI: 10.6084/m9.figshare.16626628
title: Supplementary Material for: Inflammatory Bowel Disease Patients’ Perspectives during COVID-19 Pandemic: Results from a Portuguese Survey

description: <b><i>Introduction:</i></b> Patients with inflammatory bowel disease (IBD) do not seem to be at increased risk of infection by SARS-CoV-2, but there is a concern whether immunosuppressive therapy may be associated with more severe disease. Several clinical practice recommendations have been published to help guide IBD care during the COVID-19 pandemic. Nonetheless, few studies have addressed patients’ perspectives and fears. We aimed to evaluate Portuguese IBD patients’ perspectives on the clinical management of their disease during the SARS-CoV-2 pandemic as well as the impact on their professional life. <b><i>Methods:</i></b> An anonymous electronic survey was created using REDCap and was distributed by the Portuguese Association of Inflammatory Bowel Disease (APDI) between May and August 2020. Patients’ perspectives on immunosuppressive therapy, disease management, interaction with gastroenterology departments, and the impact of the pandemic in their professional life were assessed. Patients’ proposals to improve medical care were also evaluated. Descriptive analysis and logistic regression were performed. <b><i>Results:</i></b> A total of 137 participants answered the survey (79.6% females, mean age 41.7 ± 12.1 years). Although having IBD and receiving treatment with immunosuppressors (thiopurines, steroids, or biologics) were considered promotors of anxiety, most patients (85.4%) agreed that disease remission was a priority and only a minority of patients interrupted their treatment during the pandemic. In multivariate analysis, active disease, biologic treatment, and use of corticosteroids in the last 3 months were perceived by the patients as high-risk features for increased risk of SARS-Cov-2 infection and more severe disease. Fifty-nine patients (44%) believed that their follow-up was influenced by the pandemic and only 58.8% felt that they had the opportunity to discuss their therapeutic options with their doctor. Sixty-three patients (46.0%) were working from home during the pandemic, although this decision was related to IBD and immunosuppressive therapy in only 36.5 and 39.7% of the cases, respectively. Areas where care could have been improved during the pandemic were identified by patients, namely enhancement of the communication with IBD professionals, conciliation of telemedicine with face-to-face appointments, and facilitation of the interaction between patients and employers. <b><i>Conclusion:</i></b> Most patients agreed that maintaining IBD remission is crucial, and only a minority of the patients stopped their treatment as per their own initiative. IBD status only had a small influence on patients’ professional activity during the COVID-19 outbreak, with most changes being related to the pandemic itself.
DOI: 10.6084/m9.figshare.16626628.v1
title: Supplementary Material for: Inflammatory Bowel Disease Patients’ Perspectives during COVID-19 Pandemic: Results from a Portuguese Survey

description: <b><i>Introduction:</i></b> Patients with inflammatory bowel disease (IBD) do not seem to be at increased risk of infection by SARS-CoV-2, but there is a concern whether immunosuppressive therapy may be associated with more severe disease. Several clinical practice recommendations have been published to help guide IBD care during the COVID-19 pandemic. Nonetheless, few studies have addressed patients’ perspectives and fears. We aimed to evaluate Portuguese IBD patients’ perspectives on the clinical management of their disease during the SARS-CoV-2 pandemic as well as the impact on their professional life. <b><i>Methods:</i></b> An anonymous electronic survey was created using REDCap and was distributed by the Portuguese Association of Inflammatory Bowel Disease (APDI) between May and August 2020. Patients’ perspectives on immunosuppressive therapy, disease management, interaction with gastroenterology departments, and the impact of the pandemic in their professional life were assessed. Patients’ proposals to improve medical care were also evaluated. Descriptive analysis and logistic regression were performed. <b><i>Results:</i></b> A total of 137 participants answered the survey (79.6% females, mean age 41.7 ± 12.1 years). Although having IBD and receiving treatment with immunosuppressors (thiopurines, steroids, or biologics) were considered promotors of anxiety, most patients (85.4%) agreed that disease remission was a priority and only a minority of patients interrupted their treatment during the pandemic. In multivariate analysis, active disease, biologic treatment, and use of corticosteroids in the last 3 months were perceived by the patients as high-risk features for increased risk of SARS-Cov-2 infection and more severe disease. Fifty-nine patients (44%) believed that their follow-up was influenced by the pandemic and only 58.8% felt that they had the opportunity to discuss their therapeutic options with their doctor. Sixty-three patients (46.0%) were working from home during the pandemic, although this decision was related to IBD and immunosuppressive therapy in only 36.5 and 39.7% of the cases, respectively. Areas where care could have been improved during the pandemic were identified by patients, namely enhancement of the communication with IBD professionals, conciliation of telemedicine with face-to-face appointments, and facilitation of the interaction between patients and employers. <b><i>Conclusion:</i></b> Most patients agreed that maintaining IBD remission is crucial, and only a minority of the patients stopped their treatment as per their own initiative. IBD status only had a small influence on patients’ professional activity during the COVID-19 outbreak, with most changes being related to the pandemic itself.
DOI: 10.5281/zenodo.5510789
title: The common bean aquaporin gene PvXIP1;2 identified by GWAS at seedling stage confers drought and osmotic resistance in transgenic plants

description: This is the trait data of survival rate used to conduct a GWAS
DOI: 10.5281/zenodo.5510788
title: The common bean aquaporin gene PvXIP1;2 identified by GWAS at seedling stage confers drought and osmotic resistance in transgenic plants

description: This is the trait data of survival rate used to conduct a GWAS
DOI: 10.25919/df24-6827
title: Remnant Rarity Index (RRI)

description: The Remnant Rarity Index (RRI) describes the proportion of each NVIS major vegetation group remaining in each IBRA bioregion relative to the 1750 estimates. This approach is conceptually similar to biological status of ecological vegetation communities (EVCs) in Victoria and the biodiversity status of remnant regional ecosystems in Queensland. The RRI is therefore useful as a simple proxy for conservation status for analyses that cross jurisdictional boundaries. The RRI is solely dependent upon the difference between pre-1750 and extant vegetation mapping and does not consider additional processes such as land degradation or threatening processes.
DOI: 10.22003/xfel.eu-data-002616-00
title: Sub-µs non-equilibrium dynamics of soft matter systems during X-ray induced phase transitions
DOI: 10.6084/m9.figshare.16625726
title: network_modeling

description: Data for the manuscript "Network-level modeling of stimulation-induced functional connectivity change: An optogenetic study in non-human primate cortex"
DOI: 10.6084/m9.figshare.16625726.v1
title: network_modeling

description: Data for the manuscript "Network-level modeling of stimulation-induced functional connectivity change: An optogenetic study in non-human primate cortex"